1 - 5 of 5
Dr. Schultz's research involves using magnetic resonance imaging to understand brain mechanisms and to create biomarkers that predict who has autism spectrum disorder (ASD), who will develop the disorder, and who will respond well to different interventions. More recently, he has developed a technology and innovation lab to exploit advances in perceptual computing, in order to develop more robust measurements of quantitative traits.
Relies on extensive experience in leadership positions in institution, independent, and governmental Institutional Review Boards to support investigators while they navigate multicenter research studies.
Dr. Stallings is working on intervention trials involving three chronic diseases with nutrition-related abnormalities resulting in meaningful adverse outcomes: cystic fibrosis (new drugs), sickle cell disease (vitamin A) and chronic pancreatitis (enzyme replacement drug).
Dr. Steenhoff is medical director of the Global Health Center at Children's Hospital. He serves as a global health advocate for children, seeking to optimize mutually beneficial partnerships between clinical and academic institutions in diverse settings.
Promoting collaboration between academia and industry by developing relationships with other institutions, biotechnology, pharmaceutical, and medical device companies to continue research and to commercialize CHOP research discoveries and technology-based ventures.